The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
The role of interleukin-18 in the metabolic syndrome
Open accessAbstract
The metabolic syndrome is thought to be associated with a chronic low-grade inflammation, and a growing body of evidence suggests that interleukin-18 (IL-18) might be closely related to the metabolic syndrome and its consequences. Circulating levels of IL-18 have been reported to be elevated in subjects with the metabolic syndrome, to be closely associated with the components of the syndrome, to predict cardiovascular events and mortality in populations with the metabolic syndrome and to precede the development of type 2 diabetes. IL-18 is found in the unstable atherosclerotic plaque, in adipose tissue and in muscle tissue, and is subject to several regulatory steps including cleavage by caspase-1, inactivation by IL-18 binding protein and the influence of other cytokines in modulating its interaction with the IL-18 receptor. The purpose of this review is to outline the role of IL-18 in the metabolic syndrome, with particular emphasis on cardiovascular risk and the potential effect of life style interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, in combination with IL-2, IL-18 can promote a Th2 response, while a Th1 response will be promoted in response to IL-12 (reviewed here [239]).”
From Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases (2019) · cites this paper as [239]
In the citing paper
“IL-18 is known to enhance both T cell and natural killer cell maturation and promote proinflammatory cytokine release [239].”
From Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases (2019) · cites this paper as [239]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Lifestyle interventions consisting of diet and exercise have been shown to improve several cardiovascular risk factors including the metabolic syndrome and to reduce the risk of developing type 2 diabetes [89,90].”
BackgroundObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,602
Cited by
Sorted by citations
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186
“As already stated, adipocytes behave as immune cells [72– 75] and are able to synthesize and release a huge amount of proinflammatory adipokines and cytokines including leptin, resistin, PAI-1, IL-6, TNFα, retinol-binding protein 4 (see [16]), IL-1β, monocyte chemoattractant protein-1 (MCP1), CRP, macrophage migration…”
BackgroundInterleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2017) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 621
Recent Advances on the Role of Cytokines in Atherosclerosis
Ait‐Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207415 · Cited by 606
Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases
Demine, S., Renard, P., & Arnould, T. (2019) · Cells · doi:10.3390/cells8080795 · Cited by 476
“For instance, in combination with IL-2, IL-18 can promote a Th2 response, while a Th1 response will be promoted in response to IL-12 (reviewed here [239]).”
BackgroundThe role of cytokines in the development of atherosclerosis
Fatkhullina, A. R., Peshkova, I. O., & Koltsova, E. K. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916110134 · Cited by 338
Casas, R. M., Sacanella, E., & Estruch, R. (2014) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530314666140922153350 · Cited by 294
Interleukin-18, more than a Th1 cytokine
Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.014 · Cited by 280
Casas, R. M., Sacanella, E., Urpí-Sardà, M., Chiva‐Blanch, G., Ros, E., Martínez‐González, M. Á., Covas, M., Lamuela-Raventós, R. M., Salas‐Salvadó, J., Fiol, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100084 · Cited by 250
Epigenetics of posttraumatic stress disorder: current evidence, challenges, and future directions
Zannas, A. S., Provençal, N., & Binder, E. B. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.003 · Cited by 218
Innate Immune Receptors: Key Regulators of Metabolic Disease Progression
Jin, C., Henao‐Mejia, J., & Flavell, R. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.011 · Cited by 195
IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies
Mirea, A.-M., Tack, C. J., Chavakis, T., Joosten, L. A. B., & Toonen, E. J. M. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.03.005 · Cited by 151
The role of the interleukin‐1 family in trained immunity
Moorlag, S. J. C. F. M., Röring, R. J., Joosten, L. A. B., & Netea, M. G. (2017) · Immunological Reviews · doi:10.1111/imr.12617 · Cited by 129
Inflammasomes and Metabolic Disorders: Old Genes in Modern Diseases
Robbins, G. R., Wen, H., & Ting, J. P. ‐. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.029 · Cited by 118
Cardiorespiratory fitness and the metabolic syndrome: Roles of inflammation and abdominal obesity
Wedell‐Neergaard, A., Krogh‐Madsen, R., Petersen, G. L., Hansen, Å. M., Pedersen, B. K., Lund, R., & Brüünsgaard, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194991 · Cited by 122
Interleukin-18: a regulator of cancer and autoimmune diseases
Esmaeilbeig, M., & Ghaderi, A. A. (2017) · European Cytokine Network · doi:10.1684/ecn.2018.0401 · Cited by 111
Inflammation in Metabolic Cardiomyopathy
Wenzl, F. A., Ambrosini, S., Mohammed, S. A., Kraler, S. C., Lüscher, T. F., Costantino, S., & Paneni, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.742178 · Cited by 115
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Italiani, P., Carlesi, C., Giungato, P., Puxeddu, I., Borroni, B., Bossù, P., Migliorini, P., Siciliano, G., & Boraschi, D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-94 · Cited by 103
Yousefabadi, H. A., Niyazi, A., Alaee, S., Fathi, M., & Rahimi, G. R. M. (2020) · Biological Research For Nursing · doi:10.1177/1099800420958068 · Cited by 97
Inflammatory markers and cardiovascular risk in the metabolic syndrome.
Espinola-Klein, C., Gori, T., Blankenberg, S., & Munzel, T. (2011) · Frontiers in Bioscience · doi:10.2741/3812 · Cited by 100
Molecular Basis of Health and Disease
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4 · Cited by 95
Hansen, C. H. F., Frøkiær, H., Christensen, A., Bergström, A., Licht, T. R., Hansen, A. K., & Metzdorff, S. B. (2013) · Journal of Nutrition · doi:10.3945/jn.112.172361 · Cited by 94
The ubiquitous interleukin-6: a time for reappraisal
Fisman, E. Z., & Tenenbaum, A. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-62 · Cited by 86
Shimoyama, A., Saeki, A., Tanimura, N., Tsutsui, H., Miyake, K., Suda, Y., Fujimoto, Y., & Fukase, K. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201003581 · Cited by 85
Tibuakuu, M., Kamimura, D., Kianoush, S., DeFilippis, A. P., Rifai, M. A., Reynolds, L. M., White, W., Butler, K. R., Mosley, T. H., Turner, S. T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184914 · Cited by 84
Effect of Exercise Training on Inflammation Status Among People with Metabolic Syndrome
Stensvold, D., Slørdahl, S. A., & Wisløff, U. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0140 · Cited by 80
McKie, E., Reid, J. L., Mistry, P. C., DeWall, S. L., Abberley, L., Ambery, P., & Extremera, B. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150018 · Cited by 80
Madanagobalane, S., & Anandan, S. (2012) · Indian Journal of Dermatology · doi:10.4103/0019-5154.100474 · Cited by 79
Oluwagbemigun, K., Buyken, A. E., Alexy, U., Schmid, M. C., Herder, C., & Nöthlings, U. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0813-5 · Cited by 77
Peltenburg, N. C., Schoeman, J. C., Hou, J., Mora, F., Harms, A. C., Lowe, S. H., Bierau, J., Bakker, J. A., Verbon, A., Hankemeier, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35271-0 · Cited by 68
Reverri, E. J., Randolph, J., Steinberg, F. M., Kappagoda, C., Edirisinghe, I., & Burton‐Freeman, B. M. (2015) · Nutrients · doi:10.3390/nu7085273 · Cited by 72
Inflammasomes: Key Mediators of Lung Immunity
Howrylak, J. A., & Nakahira, K. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105229 · Cited by 67
Ahmad, R., Thomas, R., Kochumon, S., & Sindhu, S. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.170 · Cited by 60
"The metabolic syndrome... is dead": These reports are an exaggeration
Tenenbaum, A., & Fisman, E. Z. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-11 · Cited by 60
ElMahdy, M. K., Helal, M. G., & Ebrahim, T. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106730 · Cited by 60
Shimoyama, A., Lorenzo, F. D., Yamaura, H., Mizote, K., Palmigiano, A., Pither, M. D., Speciale, I., Uto, T., Masui, S., Sturiale, L., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202012374 · Cited by 55
Increased expression of IL-18 in the serum and islets of type 1 diabetics
Harms, R. Z., Yarde, D. N., Guinn, Z. P., Lorenzo-Arteaga, K. M., Corley, K. P., Cabrera, M. S., & Sarvetnick, N. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.12.012 · Cited by 54
Bartlett, D. B., Connelly, M. A., AbouAssi, H., Bateman, L. A., Tune, K. N., Huebner, J. L., Kraus, V. B., Winegar, D. A., Otvos, J. D., Kraus, W. E., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0982-5 · Cited by 52
West, N. P., Pyne, D. B., Cripps, A., Christophersen, C. T., Conlon, M. A., & Fricker, P. A. (2012) · Gut Microbes · doi:10.4161/gmic.19579 · Cited by 48
Opstad, T. B., Pettersen, A. R., Arnesen, H., & Seljeflot, I. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-110 · Cited by 48
Self-citationParticulate Air pollution mediated effects on insulin resistance in mice are independent of CCR2
Liu, C., Xu, X., Bai, Y., Zhong, J., Wang, A., Sun, L., Kong, L., Ying, Z., Sun, Q., & Rajagopalan, S. (2017) · Particle and Fibre Toxicology · doi:10.1186/s12989-017-0187-3 · Cited by 47
Fujimoto, Y., Shimoyama, A., Saeki, A., Kitayama, N., Kasamatsu, C., Tsutsui, H., & Fukase, K. (2013) · Molecular BioSystems · doi:10.1039/c3mb25477a · Cited by 47
Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children
Flisiak‐Jackiewicz, M., Bobrus‐Chociej, A., Tarasów, E., Wojtkowska, M., Białokoz‐Kalinowska, I., & Lebensztejn, D. M. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/3870454 · Cited by 44
Yamaoka‐Tojo, M., Tojo, T., Wakaume, K., Kameda, R., Nemoto, S., Takahira, N., Masuda, T., & Izumi, T. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-3 · Cited by 40
Sueud, T., Hadi, N. R., Abdulameer, R., Jamil, D. A., & Al-Aubaidy, H. A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.022 · Cited by 40
Delgado, A. S. H., Roffe-Vazquez, D. N., González-Gil, A. M., Villarreal-Calderón, J. R., Tamez‐Rivera, O., Rodríguez-Gutiérrez, N. A., Castillo, E. C., Silva‐Platas, C., García‐Rivas, G., & Elizondo‐Montemayor, L. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1949415 · Cited by 41
Techatanawat, S., Surarit, R., Chairatvit, K., Khovidhunkit, W., Roytrakul, S., Thanakun, S., Kobayashi, H., Khovidhunkit, S.-O. P., & Izumi, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228921 · Cited by 41
Ponce-de-Leon, M., Linseisen, J., Peters, A., Linkohr, B., Heier, M., Grallert, H., Schöttker, B., Trares, K., Bhardwaj, M., Gao, X. Y., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.004 · Cited by 41
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 38
Brito-Luna, M. J., Villanueva‐Quintero, G., Sandoval-Talamantes, A. K., Fafutis‐Morris, M., Graciano‐Machuca, O., Sánchez‐Hernández, P. E., & Alvarado‐Navarro, A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.020 · Cited by 37
Singh, V. M. (2023) · Nutrition · doi:10.1016/j.nut.2023.112002 · Cited by 41
Borai, I. H., Shaker, Y., Kamal, M. M., Ezzat, W. M., Ashour, E., Afify, M., Gouda, W., & Elbrashy, M. M. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00004 · Cited by 36
Lorenzo, C. D., Dell’Agli, M., Colombo, E., Sangiovanni, E., & Restani, P. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/782461 · Cited by 34
Obesity development in caspase-1-deficient mice
Wang, H., Capell, W. H., JiSun, Y. O. O. N., Faubel, S. G., & Eckel, R. H. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.59 · Cited by 34
Mabrouk, R. R., Ghareeb, H., Shehab, A., Omar, K., Elkabarity, R. H., Soliman, D., & Mohamed, N. A. (2013) · PubMed · Cited by 31
Bigford, G. E., Bracchi-Ricard, V. C., Keane, R. W., Nash, M. S., & Bethea, J. R. (2013) · ASN NEURO · doi:10.1042/an20130021 · Cited by 29
Il-18, Vcam-1 and P-Selectin As Early Biomarkers in Normoalbuminuric Type 2 Diabetes Patients
Al-Rubeaan, K. A., Nawaz, S. S., Youssef, A. M., Ghonaim, M. A., & Siddiqui, K. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0359 · Cited by 26
Magnesium homeostasis and hypomagnesemia in children with malignancy
Kaplinsky, C., & Alon, U. S. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24460 · Cited by 26
Allam, O., Samarani, S., Jenabian, M.-A., Routy, J., Tremblay, C. L., Amre, D. K., & Ahmad, A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.10.016 · Cited by 26
Russell, A. L., Grimes, J. B., Cruthirds, D. F., Westerfield, J., Wooten, L., Keil, M. F., Weiser, M. J., Landauer, M. R., Handa, R. J., Wu, T. J., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-108250 · Cited by 25
Qadir, M. M. F., Elgamal, R. M., Song, K., Kudtarkar, P., Sakamuri, S. S. V. P., Katakam, P. V. G., El-Dahr, S. S., Kolls, J. K., Gaulton, K. J., & Mauvais‐Jarvis, F. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00313-z · Cited by 25
Platelet Mediated Inflammation in Coronary Artery Disease with Type 2 Diabetes Patients
Johny, E., Bhaskar, P., Alam, M. J., Kuladhipati, I., Das, R., & Adela, R. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s326716 · Cited by 23
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity
Pérez‐Gómez, J. M., Montero‐Hidalgo, A. J., Fuentes-Fayos, A. C., Sarmento‐Cabral, A., Guzmán‐Ruiz, R., Malagón, M. M., Herrera-Martínez, A. D., Gahete, M. D., & Luque, R. M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09838-w · Cited by 23
Nuszkiewicz, J., Kukulska-Pawluczuk, B., Piec, K., Jarek, D. J., Motolko, K., Szewczyk‐Golec, K., & Woźniak, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144258 · Cited by 24
Metabolic Syndrome in Pediatrics
Kursawe, R., & Santoro, N. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800141-7.00004-8 · Cited by 23
Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
Kurilenko, N., Fatkhullina, A. R., Mazitova, A., & Koltsova, E. K. (2021) · Cells · doi:10.3390/cells10020348 · Cited by 22
Parasympathetic tonus in type 2 diabetes and pre-diabetes and its clinical implications
Hadad, R., Akobe, S. F., Weber, P., Madsen, C. V., Larsen, B. S., Madsbad, S., Nielsen, O. W., Domínguez, H., Haugaard, S. B., & Sajadieh, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-22675-2 · Cited by 27
Banerjee, A., & Singh, J. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10150 · Cited by 20
(1980) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-8914-9 · Cited by 19
IL-18: The Forgotten Cytokine in Dengue Immunopathogenesis
Nanda, J. D., Ho, T., Satria, R. D., Jhan, M.-K., Wang, Y.-T., & Lin, C. (2021) · Journal of Immunology Research · doi:10.1155/2021/8214656 · Cited by 18
Jabir, N. R., Firoz, C. K., Kamal, M. A., Damanhouri, G. A., Alama, M. N., Alam, Q., Haque, A., Almehdar, H. A., & Tabrez, S. S. M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25870 · Cited by 18
Keramat, L., Sadrzadeh-Yeganeh, H., Sotoudeh, G., Zamani, E., Eshraghian, M., Mansoori, A., & Koohdani, F. (2016) · Nutrition · doi:10.1016/j.nut.2016.12.012 · Cited by 17
Simeunovic, A., Brunborg, C., Heier, M., Seljeflot, I., Dahl‐Jørgensen, K., & Margeirsdottir, H. D. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.05.020 · Cited by 17
Self-citationAkbarzadeh, M., Eftekhari, M. H., Dabbaghmanesh, M. H., Hasanzadeh, J., & Bakhshayeshkaram, M. (2013) · PubMed · doi:10.22034/iji.2013.16832 · Cited by 17
Weiss, T. W., Arnesen, H., Trøseid, M., Kaun, C., Hjerkinn, E. M., Huber, K., Wojta, J., & Seljeflot, I. (2011) · Wiener klinische Wochenschrift · doi:10.1007/s00508-011-0028-6 · Cited by 17
Self-citationMajumdar, G., Rooney, R. J., Johnson, I. M., & Raghow, R. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00048.2011 · Cited by 16
Differences in Plasma Cytokine Levels between Elite Kayakers and Nonathletes
Borges, G. F., Rama, L. M. P. L., Pedreiro, S., Alves, F., Santos, A. M., Massart, A. G. M., Paiva, A. A., & Teixeira, A. M. (2013) · BioMed Research International · doi:10.1155/2013/370354 · Cited by 16
UCP2, IL18, and miR-133a-3p are dysregulated in subcutaneous adipose tissue of patients with obesity
de Oliveira, M. S., Rheinheimer, J., Moehlecke, M., Rodrigues, M. A., Assmann, T. S., Leitão, C. B., Trindade, M. R. M., Crispim, D., & de Souza, B. M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110805 · Cited by 16
Szychowski, K. A., Skóra, B., Tobiasz, J., & Gmiński, J. (2020) · Adipocyte · doi:10.1080/21623945.2020.1770525 · Cited by 16
Cincotta, A. H., Cersósimo, E., Alatrach, M., Ezrokhi, M., Agyin, C., Adams, J. M., CHILTON, R. J., Triplitt, C. L., Chamarthi, B., Cominos, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168851 · Cited by 16
Kaminiotis, V. V., Agrogiannis, G. D., Konstantopoulos, P. S., Androutsopoulou, V. A., Korou, L. M., Vlachos, I. S., Dontas, I. A., Perrea, D. N., & Iliopoulos, D. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0573-8 · Cited by 16
Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
Nanda, J. D., Jung, C., Satria, R. D., Jhan, M.-K., Shen, T., Tseng, P., Wang, Y.-T., Ho, T., & Lin, C. (2021) · Journal of Immunology Research · doi:10.1155/2021/7652569 · Cited by 15
Fanalli, S. L., da Silva, B. P. M., Gomes, J. D., Durval, M. C., de Almeida, V. V., Moreira, G. C. M., Silva‐Vignato, B., Afonso, J., Freitas, F. A. O., Reecy, J. M., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1053021 · Cited by 15
Intzilakis, T., Hartmann, G., Mouridsen, M. R., Eugen‐Olsen, J., Kumarathurai, P., Madsbad, S., Almdal, T., Haugaard, S. B., & Sajadieh, A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12070 · Cited by 13
Mentzel, C. M. J., Alkan, F., Keinicke, H., Jacobsen, M. J., Gorodkin, J., Fredholm, M., & Cirera, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167285 · Cited by 14
Kharazmkia, A., Ahmadpoor, P., Ziaei, S., Salamzadeh, J., Pour-Reza-Gholi, F., Khoshdel, A., Samavat, S., Samadian, F., & Nafar, M. (2014) · Iranian Journal of Kidney Diseases · Cited by 14
Pyrroloquinoline quinone attenuates obesity associated low grade inflammation
Devasani, K., & Majumdar, A. S. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100134 · Cited by 13
Dozio, E., Dogliotti, G., Malavazos, A. E., Bandera, F., Cassetti, G., Vianello, E., Zelaschi, R., Barassi, A., Pelissero, G., Solimene, U., et al. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500418 · Cited by 13
Association of Insulin Resistance with Adipocytokine Levels in Patients with Metabolic Syndrome
Thomas, S., Suresh, S., Sudheesh, M., & Vijayakumar, T. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0423-7 · Cited by 12
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_3 · Cited by 11
Regulation of Development of CD56brightCD11c+ NK-like Cells with Helper Function by IL-18
Li, W., Okuda, A., Yamamoto, H., Yamanishi, K., Terada, N., Yamanishi, H., Tanaka, Y., & Okamura, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082586 · Cited by 11
Rocha, M., Daniels, K., Chandrasekaran, S., & Michopoulos, V. (2024) · American Journal of Perinatology · doi:10.1055/a-2260-5051 · Cited by 10
Role of IL-18 in adipose tissue remodeling and metabolic dysfunction
Lana, J. P., Oliveira, M. C., Silveira, A. L. M., Yamada, L. T. P., Costa, K. A., da Silva, S. V., de Assis-Ferreira, A., Gautier, E. L., Dussaud, S., Pinho, V., et al. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01507-5 · Cited by 10
Bergens, O., Nilsson, A. E., & Kadi, F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00067 · Cited by 10
Kibble, M., Khan, S. A., Ammad-ud-din, M., Bollepalli, S., Palviainen, T., Kaprio, J. A., Pietiläinen, K. H., & Ollikainen, M. (2020) · Royal Society Open Science · doi:10.1098/rsos.200872 · Cited by 10
Stiglund, N., Hagström, H., Stal, P. I., Cornillet, M., & Björkström, N. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186097 · Cited by 10
Bibliometric analysis of global research trends on pyroptosis in lung disease
Mo, W., Li, Q., Zhou, H., Shi, X., Yang, H., Xiao, Z., Wei, J., & Lv, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978552 · Cited by 10
Cade, W. T., Reeds, D. N., Overton, E. T., Herrero, P., Waggoner, A. D., Dávila‐Román, V. G., Lassa‐Claxton, S., Gropler, R. J., Soto, P. F., Krauss, M. J., et al. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-111 · Cited by 9
Giblin, L., Darimont, C., Leone, P., McNamara, L. B., Blancher, F., Berry, D. P., Castañeda‐Gutiérrez, E., & Lawlor, P. G. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0009-0 · Cited by 9
Metadata
- Authors
- Trøseid, M., Seljeflot, I., & Arnesen, H.
- Affiliations
- Oslo University Hospital (NO)
- Corresponding author
- Trøseid, Marius
- Venue
- Cardiovascular Diabetology
- Published
- 2010
- Volume
- 9
- Issue
- 1
- Pages
- 11
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC2858122
- OpenAlex
- W2116389925
- Cited by
- 155
- References
- 117
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 4 · 2021: 11 · 2020: 9 · 2019: 9 · 2018: 7 · 2017: 13 · 2016: 10 · 2015: 6 · 2014: 11 · 2013: 18 · 2012: 8
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- IL-18, metabolic syndrome, low-grade inflammation, cardiovascular risk, type 2 diabetes, atherosclerotic plaque, adipose tissue, caspase-1, IL-18 binding protein, IL-18 receptor, lifestyle intervention
- MeSH terms
- Adipose Tissue, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Life Style, Muscles, Risk Factors, Cytokines, Caspase 1, Interleukin-18, Metabolic Syndrome, Intercellular Signaling Peptides and Proteins, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review